
Is Death in Small Doses a Hit or Flop? Official Box Office Record & Profit Analysis
The official verdict is out. With a worldwide gross of $75M, Death in Small Doses is declared a Average.
📊 Box Office Snapshot
📔 Detailed Verdict Analysis
📜 Detailed Financial Report
In the competitive landscape of 1995, Death in Small Doses debuted as a Crime / Drama / Thriller / TV Movie film with significant commercial expectations. The production path for this project involved significant capital, with a reported budget of approximately $50M. In the modern film economy, recovering such an investment requires a multifaceted theatrical strategy spanning domestic and international territories.
📈 Collection Trajectory
The box office journey for Death in Small Doses has culminated in a worldwide gross of approximately $75M. This figure represents the total theatrical footprint, reflecting a Return on Investment (ROI) of 50%. The box office returns point to a steady but unspectacular run, with the film performing adequately within its genre expectations.
⚖️ Profitability & Verdict
Analyzing the multiplier effect and market sentiment, Death in Small Doses navigated the competitive landscape with an audience reception score of 6/10. When weighing the production costs against the global returns, Death in Small Doses is effectively categorized as a Average. This performance validates the commercial viability of the genre and the star power involved.
🔍 Comparables
In the context of other Crime releases, the performance of Death in Small Doses will likely influence how studios approach similar projects in the future. Whether through its innovative visual style or its narrative choices, the film's financial footprint remains a key piece of the 1995 box office narrative.